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The development of osteochondral tissue engineered interfaces would be a novel treatment for traumatic
injuries and aging associated diseases that affect joints. This study reports the development of a bilayered
scaffold, which consists of both bone and cartilage regions. On the other hand, amniotic ﬂuid-derived
stem cells (AFSCs) could be differentiated into either osteogenic or chondrogenic cells, respectively. In
this study we have developed a bilayered scaffolding system, which includes a starch/polycaprolactone
(SPCL) scaffold for osteogenesis and an agarose hydrogel for chondrogenesis. AFSC-seeded scaffolds were
cultured for 1 or 2 weeks in an osteochondral-deﬁned culture medium containing both osteogenic and
chondrogenic differentiation factors. Additionally, the effect of the presence or absence of insulin-like
growth factor-1 (IGF-1) in the culture medium was assessed. Cell viability and phenotypic expression
were assessed within the constructs in order to determine the inﬂuence of the osteochondral differenti-
ation medium. The results indicated that, after osteogenic differentiation, AFSCs that had been seeded
onto SPCL scaffolds did not require osteochondral medium to maintain their phenotype, and they pro-
duced a protein-rich, mineralized extracellular matrix (ECM) for up to 2 weeks. However, AFSCs differen-
tiated into chondrocyte-like cells appeared to require osteochondral medium, but not IGF-1, to synthesize
ECM proteins and maintain the chondrogenic phenotype. Thus, although IGF-1 was not essential for cre-
ating osteochondral constructs with AFSCs in this study, the osteochondral supplements used appear to
be important to generate cartilage in long-term tissue engineering approaches for osteochondral inter-
faces. In addition, constructs generated from agarose–SPCL bilayered scaffolds containing pre-differenti-
ated AFSCs may be useful for potential applications in regeneration strategies for damaged or diseased
joints.
 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.1. Introduction
Osteochondral interfaces are one of the most susceptible areas
in the human body to traumatic injuries and aging associated dis-
eases, such as osteoarthritis [1]. Understanding and mimicking the
complexity of the osteochondral system are critical for designing a
successful tissue engineering (TE) approach that can restore the
functionality of a joint. However, bone and cartilage, which are
the tissues that make up the osteochondral interface, have differ-
ent molecular compositions and cellular organizations, which cre-
ate differences in structural and mechanical properties, betweenia Inc. Published by Elsevier Ltd. A
: +1 336 713 7290.
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amniotic ﬂuid-derived stem cethese tissues. Thus, current TE strategies are hampered by the dif-
ﬁculties inherent in designing a seamless interface between these
two very different tissues.
The ideal cell source for osteochondral TE strategies has not yet
been found. The cell source should be proliferative, yet it should
possess the phenotypic plasticity to differentiate into the various
cell types that form the osteochondral interface. Recently, amniotic
ﬂuid-derived stem cells (AFSCs) have been shown to have the
capacity to differentiate along both the chondrogenic [2,3] and
osteogenic [2] lineages. Also, the use of AFSCs does not raise the
ethical concerns that are associated with the use of embryonic
stem cells for research and therapy [4,5].
Osteochondral interfaces are exposed to a number of different
in vivo stresses and strains that result from the patient’s dailyll rights reserved.
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support, a scaffold for osteochondral regeneration should generate
an efﬁcient and integrated interface which enables different cell
types to communicate and interact while keeping these various
cells and their functions in the proper structural compartment.
Agarose hydrogels have previously been used for cell culture and
cartilage TE strategies [6–9], because the soft, ﬂexible structure
of this natural based gel recreates a three-dimensional environ-
ment suitable for chondrocyte maintenance [7] as well as the dif-
ferentiation of mesenchymal stem cells (MSCs) into the
chondrogenic lineage [7]. In addition, SPCL scaffolds, which are a
blend of starch and polycaprolactone, have been previously used
in TE strategies designed for bone regeneration and replacement
[10–14] as well as for cartilage applications [15,16]. SPCL scaffolds
are biodegradable and biocompatible, and they are based on natu-
rally occurring materials. These scaffolds support the adhesion and
proliferation of several cell types, including endothelial [10] and
stem cells [12], and assist bone neoformation in vivo, especially
when used in the implantation of cell-seeded scaffolds [12].
In addition to physical support (scaffold) and a biological inter-
face (cells), the biochemical factors involved in stimulating cell-to-
cell communication, differentiation, and maintenance of pheno-
type should also be considered when designing a tissue engineer-
ing approach. Transforming growth factor-beta (TGF-b) is
frequently used as a standard factor in media designed to induce
chondrogenic differentiation. TGF-b is involved in chondrogenesis
[17], including differentiation of progenitor cells into chondro-
cytes, and induces proliferation and ECM production in articular
chondrocytes [18,19]. Conversely, in bone differentiation, dexa-
methasone, ascorbic acid and b-glycerophosphate are commonly
used supplements for culture media designed to induce osteogenic
differentiation of various stem cells. Dexamethasone, a synthetic
glucocorticoid, has been shown to induce osteogenic differentia-
tion of osteoprogenitor cells from adult bone marrow stromal-de-
rived cells [20,21]. Ascorbic acid plays an essential role in the
structure and function of skeletal tissues as it is required for hu-
man collagen synthesis. Moreover, when a potential source of
phosphate ions, such as b-glycerophosphate [21], is also present,
a zone of hydroxyapatite-containing mineralized ECM is formed
within the collagen ﬁbrils [22], and this mineralization of the ma-
trix is essential for formation of bone tissue. However, although os-
teo- and chondrogenic media are frequently described in the
literature and are used to induce the differentiation of cells into
these lineages, an efﬁcient osteochondrogenic medium, which
would be able to support both osteo- and chondrogenesis and
the co-culture of both bone and cartilage cells, has not been com-
pletely established, although some attempts have been described
[23].
In this study, we aimed to develop a novel approach to design-
ing functional scaffolds that would support an osteochondral inter-
face. A novel osteochondral medium, designed to support both
bone and cartilage cells, was also developed by combining some
of the growth factors and nutrients associated with osteo- and
chondrogenic media. Furthermore, insulin-like growth factor-1
(IGF-1) was also evaluated as a potential factor for supporting
osteochondral constructs in vitro, since it is involved in several
developmental and physiological functions [24] of bone and carti-
lage, including cartilage and bone development; chondrocyte pro-
liferation and ECM synthesis [25,26], and osteoblast proliferation
and bone formation [27].
To test the osteochondral media and our novel scaffold design,
human AFSCs were either cultured on SPCL scaffolds and differen-
tiated into osteogenic cells or encapsulated in agarose gel and dif-
ferentiated into chondrogenic cells. These two cell seeded scaffolds
were then brought together in order to form a combination of scaf-
folds that would provide a highly supportive scaffold for bonePlease cite this article in press as: Rodrigues MT et al. Bilayered constructs aime
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ing single constructs were cultured for 1 or 2 weeks in our novel
osteochondral media, either with or without IGF-1. At each time
point, the constructs were characterized for expression of bone
and cartilage speciﬁc markers to evaluate the inﬂuence of the cul-
ture media on the osteogenic or chondrogenic phenotype of the
differentiated cells.2. Materials and methods
2.1. Preparation of osteochondral constructs
SPCL scaffolds were produced by the ﬁber melt-spinning pro-
cess [11] using an extruder equipped with a 12 mm diameter
screw and a 0.5 mm monoﬁlament die. Extrusion was performed
at 150 C and the screw speed 1 rpm. Hot ﬁber was driven into a
cooling water bath (13 C) and cold-drawn after the bath, using a
caterpillar with a speed of 21 mmin1 and a winding unit with a
speed of 28 mmin1. Fibers were produced in a range of 120–
500 lm diameter. Fiber-mesh scaffolds were prepared by a ﬁber
bonding process consisting of cutting and sintering the ﬁbers ob-
tained by the melt-spinning method [11]. Brieﬂy, a selected
amount of ﬁbers was placed inside a mold, and heated in an oven
at 120 C. Then, immediately after removing the molds from the
oven, the ﬁbers are slightly compressed and cooled to 15 C. Prior
to the cell culture assays, all scaffolds were cut into cylinders and
sterilized using ethylene oxide.2.2. Cell culture and seeding
Human AFSCs were cultured in basic amniotic ﬂuid cell (BAFC)
medium. The BAFC medium (500 ml) contained liquid a-MEM (Hy-
Clone Laboratories Inc., Logan, Utah, USA) with 18% Chang B (Irvine
Scientiﬁc, Santa Ana, CA, USA) and 1% Chang C (Irvine Scientiﬁc)
media as well as 2% L-glutamine (HyClone Laboratories Inc.) and
15% embryonic screened fetal bovine serum (ES-FBS, HyClone Lab-
oratories Inc.). AFSC basal medium, also called BAFC, was previ-
ously described [2] as the medium that best nourishes amniotic
ﬂuid stem cells in maintenance cultures.
Brieﬂy, back-up human amniocentesis cultures were harvested
by trypsinization, and immunoselected with c-kit. AFSCs were then
subcultured at a dilution of 1:8 and not permitted to expand be-
yond 60% of conﬂuence. AFSCs were passaged 2–3 times (passage
18–20) in BAFC medium. Then AFSCs were either encapsulated in
agarose hydrogels (2%, Invitrogen, Carlsbad, CA, USA) at a concen-
tration of 2  106 cells ml1 for the chondrogenic layer of the bilay-
ered scaffold or seeded onto SPCL scaffolds (4 mm diameter and
5 mm length) at a concentration of 8.6  105 cells/scaffold for the
osteogenic layer (Fig. 1).
These cell-seeded scaffolds were cultured for 2 days in BAFC
culture medium, and then the medium was exchanged for either
chondrogenic (agarose hydrogel) or osteogenic (SPCL scaffold)
media. The chondrogenic medium consisted of DMEM (HyClone
Laboratories Inc.) supplemented with 1% antibiotic/antimicotic
solution, 50 lg ml1 L-ascorbic acid (Sigma, St. Louis, MO, USA),
1 mM dexamethasone (Sigma), 40 lg ml1 L-proline (Sigma),
100 lg ml1 sodium pyruvate (Sigma), 1% ITS (100, Sigma) and
10 ng ml1 TGF-b1 (Sigma). The osteogenic mediumwas composed
of DMEM (HyClone Laboratories Inc.) supplemented with 10% FBS
(HyClone Laboratories Inc.) and the following osteogenic supple-
ments: 100 nM dexamethasone (Sigma), 50 lM L-ascorbic acid
and 10 mM glycerol-2-phosphate disodium salt hydrate (Sigma).
Chondrogenic differentiation of AFSCs in the agarose hydrogels
was assessed after 7, 14 and 21 days in the chondrogenic media,
and then the gels were characterized for cellular viability with ad at osteochondral strategies: The inﬂuence of medium supplements in the
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Fig. 1. Photograph of osteochondral scaffold.
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aggrecan and collagen type II.
After both chondrogenic differentiation and osteogenic differen-
tiation occurred in the two scaffolds, the constructs were combined
by adding a drop of agarose (2%) between the cell-encapsulated and
the SPCL scaffolds to promote bonding of the two layers. Then, the
bilayered constructs were cultured for 2 weeks in co-culture med-
ium under static conditions to evaluate whether this medium could
maintain differentiated AFSCs in both chondrogenic and osteogenic
phenotypes at the same time. The co-culture media (500 ml) was
composed of DMEM-LG (HyClone Laboratories Inc.), 4 lg ml1 so-
dium pyruvate, ITS (1), 5 mM glycerol-2-phosphate, 50 lg ml1
L-ascorbic acid, 10 mM dexamethasone, and 40 lg ml1 L-proline.
In some studies, the growth factor IGF-1 (100 ng ml1, Invitrogen)
was added to the co-culture medium (IGF-1 (+)). After 7 and
14 days in the co-culture media, constructs were removed and
characterized for the osteo- or chondrogenic markers mentioned
above. BAFC medium (i.e. the basal conditions) was used as a con-
trol for this experiment.
2.3. Cell viability assay with Calcein AM
AFSCs encapsulated in the agarose gels were rinsed in PBS (Hy-
Clone Laboratories Inc.) and then were incubated in PBS containing
3 lMCalcein AM (Molecular Probes, Invitrogen) for 30 min at 37 C
in a 5% CO2 environment. This incubation was followed by a quick
rinse in PBS and overnight ﬁxation in 10% buffered formalin (Sur-
gipath Medical Ind., Inc., Richmond, IL, USA) at 4 C. AFSC viability
was detected using a confocal microscope (Axiovert 100M, Zeiss,
Germany) equipped with argon/He–Ne laser sources.
2.4. Alizarin red staining and calcium quantiﬁcation assay
Alizarin red (AR) staining was directly evaluated in AFSC–SPCL
constructs for the assessment of osteogenesis after 7, 14 and
21 days of culture with osteogenic supplements. An alizarin red
solution (0.2%, Sigma-Aldrich, USA) was prepared and pH-adjusted
to pH 4.1–4.3. Samples were cut in half and then stained viaPlease cite this article in press as: Rodrigues MT et al. Bilayered constructs aime
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by a water rinse to wash away non-speciﬁc staining.
After acquiring images of the stained AFSC–SPCL constructs
using an Olympus SP-570UZ digital camera, AR staining was solu-
bilized in cetylpyridinium chloride (Sigma, USA) at pH 7.0 for
15 min under mild agitation and the calcium bonded to the AR
was quantiﬁed at 562 nm using a plate reader (SpectraMax MS,
Molecular Devices).
2.5. Quantiﬁcation of alkaline phosphatase (ALP) activity
ALP in AFSC–SPCL constructs was measured by an enzymatic
reaction followed by colorimetric analysis. At each time point (7,
14 or 21 days in osteogenic medium), cells were rinsed in PBS
and placed in a microtube containing 1 ml of ultra-pure water
and kept frozen at 80 C until testing. Afterwards, samples were
thawed and sonicated brieﬂy for 15 min in order to rupture any
cells that might have maintained membrane integrity after the os-
motic treatment and the freeze/thaw cycle. Then, a substrate solu-
tion consisting of 0.2% (wt/v) p-nitrophenyl phosphate (Sigma,
Germany) in a substrate buffer with 1 M diethanolamine HCl (Pan-
reac, Spain), at pH 9.8 was added to each sample, at a proportion of
60 ll of solution to 20 ll of sample.
Samples were incubated in the dark for 45 min at 37 C. This
reaction was followed by the addition of a stop solution (2 M NaOH
(Panreac, Spain) plus 0.2 mM EDTA (Sigma, Germany)) to end the
color development reaction. Standards were prepared with p-
nitrophenol (10 lmol ml1) (Sigma, Germany) in order to achieve
ﬁnal concentrations ranging between 0 and 0.3 lmol ml1. Sam-
ples and standards were analyzed in triplicate.
The absorbance was read using a microplate ELISA reader (Syn-
ergie HT, BioTek) at 405 nm and concentration values were deter-
mined by interpolation using a standard curve established by the
standards.
2.6. Scanning electronic microscopy (SEM)
Bilayered constructs were rinsed in PBS, ﬁxed in 10% buffered
formalin overnight, and dehydrated in a series of ethanol concen-
trations and critical point dried (EMS850X, Electron Microscopy
Sciences, Hatﬁeld, PA, USA). The scaffolds were then sputtered with
gold (Hummer 6.2 sputtering system, Anatech Ltd, Union City, CA,
USA). This procedure destroys the structure and morphology of
AFSC–agarose hydrogels and therefore, SEM observation was only
used for the AFSC–SPCL constructs of the OC system (Hitachi S-
2600N, Hitachi Science Systems, Ltd, Japan). Additionally, in order
to detect speciﬁc ions that eventually became present at the sur-
face of cell seeded SPCL constructs on the ECM, such as calcium
(Ca2+) and phosphorus (P), an energy dispersive spectroscopy
(EDS) analysis was performed with EDAX (Pegasus X4M, EDS/EBSD,
EDAX BV, JC Tilburg, Netherlands). Each EDS analysis involved four
replicates (n = 4) per study condition.
2.7. Histological characterization
For histological evaluation, the samples were rinsed in PBS,
ﬁxed in 10% buffered formalin overnight and processed using a tis-
sue processor (Microm STP120, MICROM International GmbH,
Walldorf, Germany). Next, each sample was embedded in parafﬁn
blocks (Microm EC 350-2, ThermoScientiﬁc, Spain), and 10 lm
thick sections were cut and stained with safranin-O (Fluka, Swit-
zerland). Safranin-O is a cationic dye frequently used for the detec-
tion of cartilage. Following deparafﬁnization of AFSC–agarose
samples, slides were stained with Weigert’s iron hematoxylin
working solution (Sigma-Aldrich, Germany) for 7 min. Samples
were rinsed in tap water for 10 min, and subsequently rinsedd at osteochondral strategies: The inﬂuence of medium supplements in the
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in 0.1% safranin-O solution for 5 min.
Immunoﬂuorescence analysis for collagen type II and aggrecan
was also carried out. Sections were cut from the parafﬁn blocks,
deparafﬁnized and rehydrated with a graded series of ethanol con-
centrations. Prior to incubation with primary antibodies for either
mouse anti-collagen II (MAB1330, Millipore, Spain) or mouse anti-
human aggrecan (MCA1452, Serotec, Germany; dilution 1:25),
slides were blocked with horse serum (VectorLabs) for 45 min. This
was followed by an incubation with 4,6-diamidino-2-phenyindole,
dilactate (DAPI at 5 lg/ll; D9564, Sigma, Germany) for 15 min.
Next, samples were formalin-ﬁxed for an additional 30 min to pre-
vent ﬂuorescence dilution 1:75. Samples were incubated with pri-
mary antibodies prepared in antibody diluent with background
reducing components from Dako (Dako, Denmark) overnight at
4 C. After rinsing in PBS, the samples were incubated with rabbit
anti-mouse Alexa Fluor 488-conjugated secondary antibody
(A11059, Invitrogen, Spain; dilution 1:200) for 1 h at room temper-
ature. Samples were washed again in PBS from leaching out of the
stained areas.
Samples were observed under a microscope (Zeiss Imager Z1m,
Germany) and images were acquired using a digital camera (Axio-
CamMRm5). Multiple sections were viewed per time point and per
antibody group.
Negative controls were assessed for immunoﬂuorescence detec-
tion. Negative controls followed the same protocol as the test sam-
ples without the incubation with the primary antibody.
Immunoﬂuorescence on the osteogenic layer (AFSC–SPCL con-
structs) of the bilayered construct was performed directly on the
sample after the system was disassembled to assess the presence
of the bone factor RunX-2. Initially, samples were rinsed and incu-
bated with a protein blocking solution (Dako, Denmark), followed
by an incubation with antibody to RunX-2 (Rabbit polyclonal to
RUNX2, ab23981, Abcam, Cambridge, MA, USA) (1:100 dilution)
prepared in antibody diluent with background reducing compo-
nents from Dako. Antibody binding was assessed using anti-rabbit
AlexaFluor 488 (Molecular Probes, 1:200 dilution) as a secondary
antibody.2.8. Statistical analysis
All quantitative results are expressed as the mean ± standard
deviation. One-way ANOVA followed by Bonferroni’s multiple
comparison test was used in calcium and ALP quantiﬁcation assays
while EDS analysis for the atomic percentage of calcium and phos-
phorus was assessed by two-way ANOVA followed by Bonferroni’s
multiple comparison test. Both one-way and two-way ANOVA
were assessed to determine whether differences between sample
groups were signiﬁcant. Differences were considered signiﬁcant
when the p value was <0.05.3. Results
3.1. AFSC–agarose scaffold
The AFSC–agarose encapsulation systems were stable during
the experimental period. AFSCs remained viable during the 21-
day culture period regardless of the type of medium used (basal
or chondrogenic), as shown in Fig. 2. Nevertheless, the intensity
of Calcein AM ﬂuorescence in the AFSCs in basal culture media ap-
peared to be higher than that seen in the chondrogenic environ-
ment. Furthermore, the differentiation of AFSCs into
chondrocyte-like cells was assessed by examining protein expres-
sion of collagen type II and aggrecan by immunoﬂuorescent
analysis.Please cite this article in press as: Rodrigues MT et al. Bilayered constructs aime
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culture of AFSCs encapsulated in agarose gel in both basal and
chondrogenic cultures. Collagen II expression is lost in basal med-
ium at week 2 and, by week 3, reappears and increases, while
AFSC–agarose gels cultured in chondrogenic medium show a more
constant expression of collagen II with the time in culture (Fig. 3).
As observed in Fig. 4, overall, aggrecan expression is less than that
of collagen II. In basal medium, AFSCs encapsulated in agarose
hydrogels expressed a low level of aggrecan for the 3 weeks of this
experiment (Fig. 4).
Although cells are present as observed by DAPI staining (inset
images), in chondrogenic medium the intensity seems to be lower
than in basal conditions.
Brieﬂy, our results show that in the agarose gels, strong collagen
type II expression and lower expression of aggrecan are present
with some ﬂuctuations from week 2 to week 3.
3.2. AFSC–SPCL scaffold
The osteogenic potential of AFSCs on SPCL scaffolds was evalu-
ated by ALP activity, alizarin red staining and observation of the
synthesis of a calciﬁed mineralized matrix.
As observed in Fig. 5, ALP levels were very low at day 0 (AFSC–
SPCL constructs without osteogenic supplements). After 1 week in
osteogenic medium, ALP activity increased signiﬁcantly (p < 0.05),
although enzymatic values stabilized from day 7 to day 14
(p > 0.05). Nevertheless, at day 21, the amount of ALP measured
was considerably higher than any other end point in the experi-
ment (p < 0.05).
Only the image of AFSC–SPCL constructs at day 21 in osteogenic
medium developed the characteristic alizarin red color associated
with the alizarin–calcium complex that forms in the presence of
calcium (Fig. 6).
Moreover, the observed stain is homogeneously dispersed
throughout the ﬁbers of the scaffold. After stain dissolution, the
calcium content graph clearly indicates the increase in calcium lev-
els in AFSC–SPCL constructs after 21 days in osteogenic culture
(p < 0.05), when compared to the other end points in this study.
3.3. Agarose–SPCL bilayered system
The AFSCs seeded onto the SPCL scaffold proliferated well and
were able to differentiate to osteogenic cell type in the different
culture media. In the SEM micrographs of these constructs
(Fig. 7), the cells were distributed throughout the scaffold, and
some mineralization nodules could be seen at the surface of the
SPCL ﬁbers (indicated by white arrows in Fig. 7), suggesting the
formation of a calciﬁed ECM. Larger mineralized aggregates were
found when IGF-1 was added to the OC culture medium after
1 week of culture in this medium. Although these nodules did
not increase in size with time, the mineralization observed in the
SPCL constructs was stable and was still evident after 2 weeks of
culture in the OC medium.
EDS analysis was also performed at the surface of the constructs
after assembly of the OC constructs. Two EDS analyses were con-
sidered; the ﬁrst was broader and included several areas of the
construct that contained cells with and without mineralization
nodules (Table 1), and the second analysis included only areas in
which mineralization was present (Table 2).
The detection of calcium (Ca) and phosphorus ions (P) via EDS
has been associated with the production of mineralized matrices
by cells. In this study, P, Ca and the ratio Ca/P were assessed in
the AFSC–SPCL layer after 7 and 14 days in osteochondral cultures
(Figs. 8 and 9).
Calcium and phosphorus tend to decrease with culture time,
with an exception made for constructs cultured in IGF (+) medium,d at osteochondral strategies: The inﬂuence of medium supplements in the
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Fig. 2. Cell viability (Calcein AM) of AFSCs encapsulated in agarose hydrogels, after 7, 14 or 21 days in chondrogenic and basal media (control). Scale bar represents 200 lm.
Fig. 3. Immunoﬂuorescence analysis of collagen type II expression in AFSCs encapsulated in agarose gels after 7, 14 or 21 days in chondrogenic and basal media (control).
Scale bar represents 100 lm, magniﬁcation, 200.
Fig. 4. Immunoﬂuorescence analysis of aggrecan expression in AFSCs encapsulated in agarose hydrogels after 7, 14 or 21 days in chondrogenic or basal media (control). Scale
bar represents 100 lm, magniﬁcation, 200.
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Fig. 5. Alkaline phosphatase activity (nmol h1 per lg DNA) of AFSCs seeded onto
SPCL scaffolds after 7, 14 or 21 days in osteogenic medium. Day 0 represents a
control of the experiment where AFSCs were seeded and maintained in AFSC basic
medium for two days, without the addition of osteogenic medium. Data are
normalized per amount of DNA of each construct and values are represented as
mean ± SD. The symbol * denotes end points with statistically signiﬁcant differ-
ences (p < 0.05) via the one-way ANOVA method.
Fig. 6. Alizarin red staining and calcium content (lg ml1 per well) of AFSC–SPCL
constructs cultured in osteogenic medium for 0, 7, 14 or 21 days. Day 0 represents a
control of the experiment where AFSCs were seeded and maintained in AFSC basic
medium for two days, without the addition of osteogenic medium. Values are
represented as mean ± SD. The symbol * denotes end points with statistically
signiﬁcant differences (p < 0.05) via the one-way ANOVA method.
Fig. 7. SEM micrographs of the osteogenic layer (AFSC-seeded SPCL scaffold) of the bil
medium supplemented with IGF-1 while IGF-1() refers to the same culture medium wi
and maintenance, and was used as a control. White arrows indicate the presence of mi
conditions. Scale bar represents 100 lm, magniﬁcation 300.
Table 1
Results obtained from EDS analysis of the atomic percentage (at.%) of several ions
present in AFSC–SPCL layer after 7 or 14 days in the OC culture media (broad
analysis).
At.% P Ca Ca/P
7d IGF-1 (+) 0.385 ± 0.199 (⁄) 0.380 ± 0.072 0.840 ± 0.044
7d IGF-1 () 0.553 ± 0.041 (⁄) 0.730 ± 0.286 (⁄) 1.350 ± 0.666
7d basal 1.240 ± 0.451 (⁄) 1.328 ± 0.681 (⁄) 1.039 ± 0.153
14d IGF-1 (+) 0.995 ± 0.660 (⁄) 0.883 ± 0.977 (⁄) 0.786 ± 0.299
14d IGF-1 () 0.485 ± 0.142 (⁄) 0.518 ± 0.225 (⁄) 1.050 ± 0.127
14d basal 0.708 ± 0.214 (⁄) 0.965 ± 0.431 (⁄) 1.313 ± 0.312
Represented ions are: P (phosphorus), Ca (calcium). Ca/P represents the ratio of
calcium/phosphorus. The symbol * denotes statistical signiﬁcance (p < 0.05)
between the atomic percentage of ions found in broad analysis and mineral
aggregate analysis.
Table 2
Results obtained from EDS analysis of the atomic percentage (at.%) of several ions
present in AFSC–SPCL layer after 7 or 14 days in the OC culture media. EDS analysis
was performed on areas of the constructs containing mineralized aggregates.
At.% P Ca Ca/P
7d IGF-1 (+) 2.550 ± 1.293 (⁄) 2.503 ± 0.261 0.942 ± 0.062
7d IGF-1 () 3.128 ± 0.527 (⁄) 3.363 ± 0.767 (⁄) 1.073 ± 0.026
7d basal 5.345 ± 0.727 (⁄) 5.588 ± 0.822 (⁄) 1.043 ± 0.069 (⁄)
14d IGF-1 (+) 2.865 ± 1.557 (⁄) 3.135 ± 2.555 (⁄) 1.042 ± 0.163
14d IGF-1 () 3.288 ± 0.675 (⁄) 3.593 ± 0.705 (⁄) 1.098 ± 0.076
14d basal 3.670 ± 0.963 (⁄) 4.553 ± 1.301 (⁄) 1.240 ± 0.042 (⁄)
Represented ions are: P (phosphorus), Ca (calcium). Ca/P represents the ratio of
calcium/phosphorus. The symbol * denotes statistical signiﬁcance (p < 0.05)
between the atomic percentage of ions found in broad analysis and mineral
aggregate analysis; with the exception of Ca/P values in which the symbol * denotes
statistical signiﬁcance (p < 0.05) between 7 and 14 days in the basal culture media.
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Some variations were observed with culture time and media in the
broad analysis but they were not statistically relevant (p > 0.05)
(Fig. 8, Table 1). The atomic concentrations of both of these miner-
als were higher (p < 0.05) on the mineral nodules formed than the
ones observed in the broader analysis shown in Table 1 and Fig. 8,
with the exception made for calcium detected in AFSC–SPCL scaf-
folds after 7 days in culture medium with IGF (+). Interestingly,
in the mineral aggregates analysis, the higher atomic percentagesayered scaffolds after 7 or 14 days in OC culture media. IGF-1(+) indicates culture
thout IGF-1. ‘‘Basal’’ represents the basic medium currently used for AFSC expansion
neralization nodules dispersed throughout the constructs in the different culturing
d at osteochondral strategies: The inﬂuence of medium supplements in the
lls. Acta Biomater (2012), http://dx.doi.org/10.1016/j.actbio.2012.04.013
Fig. 8. EDS analysis of the atomic percentage (at.%) of calcium and phosphorus ions present in AFSC–SPCL layer after 7 or 14 days in the OC culture media. The symbol
* denotes for statistical differences (p < 0.05) between the atomic percentage of ions found in broad analysis and mineral aggregate analysis via the two-way ANOVA method.
Fig. 9. EDS analysis of the atomic percentage (at.%) of calcium and phosphorus ratio of AFSC–SPCL layer after 7 or 14 days in the OC culture media. Symbol * denotes for
statistical differences (p < 0.05) via the two-way ANOVA method.
M.T. Rodrigues et al. / Acta Biomaterialia xxx (2012) xxx–xxx 7of calcium and phosphorus were observed in the basal medium
condition (p > 0.05) (Fig. 8, Table 2).
Afterwards, the Ca/P ratio was analyzed (Fig. 9) so as to com-
pare its proximity to the ratio observed in natural bone: 1.67 [28].
In the broad analysis, the Ca/P ratio was close to 1 at both 7 and
14 days in constructs maintained in OC medium without IGF-1 and
basal medium, while in AFSC–SPCL scaffolds cultured in the
presence of IGF-1, the Ca/P ratio was found to be close to 0.8.
Despite these variations, no signiﬁcant differences were found
with culture time or culture media. When the analysis wasPlease cite this article in press as: Rodrigues MT et al. Bilayered constructs aime
osteogenic and chondrogenic differentiation of amniotic ﬂuid-derived stem ceperformed speciﬁcally on mineralized nodules, Ca/P ratios showed
closer values among different culture conditions (Table 2, Fig. 9).
When the Ca/P ratio was calculated, all culture conditions but
one resulted in a ratio of 1 (Table 2). Furthermore, the constructs
cultured for 14 days in basal medium after the OC assembly were
found to have Ca/P ratio closer to that found in healthy bone
(1.67) [28], namely 1.313 ± 0.312 and 1.240 ± 0.042, after an EDS
broad analysis and on mineralized aggregates, respectively.
In our previous study [29], AFSCs were shown to express RunX-
2 during osteogenic differentiation over a period of up to 3 weeksd at osteochondral strategies: The inﬂuence of medium supplements in the
lls. Acta Biomater (2012), http://dx.doi.org/10.1016/j.actbio.2012.04.013
8 M.T. Rodrigues et al. / Acta Biomaterialia xxx (2012) xxx–xxxin osteogenic medium. In the present study, we analyzed possible
differences in RunX-2 expression 2 weeks after the novel OC media
was added to the constructs (Fig. 10). RunX-2 expression was high-
er when the cells were cultured in OC media than when they were
cultured in basal medium.
Cell viability in the AFSC-containing agarose gels was qualita-
tively analyzed using a Calcein AM assay after the chondrogenic
differentiation process. Fig. 11 indicates that most cells remained
viable during the culture period, and viability was independent
of the medium used for culture. Furthermore, cellular viability
was high both at the surface/border and in the center areas of
the gels, indicating that the agarose gels were permeable enough
to allow the exchange of nutrients and gases between the culture
media and the encapsulated cells.
Collagen type II expression within the gels was assessed by
immunoﬂuorescence. Fig. 12 indicates that collagen type II was
present in the constructs for up to 14 days after the addition of
OC media. However, expression of this chondrogenic marker was
similar in the assembled bilayered construct than in AFSC-contain-
ing agarose gels alone, and this was true whether the constructs
were cultured in basal or chondrogenic media.
The exception is AFSC–agarose constructs cultured under basal
medium for 14 days, which increased in OC media in this period of
time. According to Fig. 12, the collagen II expression seems to be
increased in the culture medium without IGF supplementation.
In the presence of IGF, collagen II tends to be more abundant at
both 7 and 14 days of osteochondral culture.
The expression of aggrecan in the bilayered constructs was very
mild at 7 days in all osteochondral media. Nevertheless, by day 14
some of the expression is already restored, yet with lower levels
than collagen II. This suggests that the presence of OC media inﬂu-
ences type II collagen expression in the bilayered system (Fig. 13).
Safranin-O staining is used to identify areas of cartilage produc-
tion in tissue sections. When we performed this stain on sections
taken from the bilayered OC constructs, the chondrogenic layer
(AFSC–agarose gel) stained positively in sections from all samples
cultured in OC medium without IGF-1 after 14 days of culture, as
shown in Fig. 14. In basal medium as well as in medium containing
IGF-1, the safranin-O staining intensity is very low.
4. Discussion
4.1. AFSC–agarose scaffold
The AFSC–agarose encapsulation systems remained viable
during the 21-day culture period as indicated by the intensity of
Calcein AM ﬂuorescence in Fig. 1.
In native cartilage, only a limited number of chondrocytes are
able to form functional cartilage tissue. In addition, in nativeFig. 10. Immunoﬂuorescence analysis of RunX-2 expression in the osteogenic layer (AF
culture media. IGF-1(+) indicates culture medium supplemented with IGF-1 while IGF-1
medium currently used for AFSC expansion and maintenance, and was used as a contro
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tain a healthy extracellular matrix, and this suggests that relatively
few cells are able to provide functional cartilage tissue. In our
study, we based our cell numbers on this naturally occurring phe-
nomenon, and thus, we reduced the number of encapsulated cells
to a minimum number at which cells were still able to maintain
the capacity to differentiate and produce extracellular matrix.
Furthermore, the low cell density proposed is supported by other
cartilage studies [30–32]. Some studies also state that the low cell
density in agarose gels allows low amounts of regulation factors to
be effective [30], which could also provide some evidence that suc-
cessful chondrogenic differentiation is possible with low cell num-
bers in vitro. Interestingly, the viability of AFSCs in basal culture
medium appeared to be higher than that seen in the chondrogenic
environment. As basal medium is speciﬁcally formulated for cell
maintenance and expansion, AFSCs may have been able to prolifer-
ate at a higher rate when cultured in basal medium in AFSC–
agarose constructs. Conversely, chondrogenic medium directs
AFSCs towards the chondrogenic differentiation process and thus
stimulates the cells to stop proliferating and begin expressing
ECM proteins. This result is expected, because during mammalian
development, proliferation usually inhibits differentiation, while
differentiation is accompanied by cell cycle withdrawal [33]. The
inverted relationship between proliferation and differentiation
has been previously reported in osteoprogenitor cells [34]. Besides
water, the cartilage matrix consists of macromolecules in which
collagen type II (80% of the total tissue collagen) and proteogly-
cans (aggrecan) are the main structural representatives [35], and
these molecules are responsible for tissue formation. When MSCs
differentiate into chondrocytes, collagen type II expression begins
in a ﬁnal stage of undifferentiated MSCs, and then increases signif-
icantly in the chondroprogenitor stage and again as chondropro-
genitor cells differentiate into chondrocytes [36]. This may
explain why collagen type II is expressed at all time points in this
study. Undifferentiated AFSCs tend to express a number of markers
that are similar to MSCs [2,37], indicating that they may be similar
or related cells. Thus, it is not surprising that the chondrogenic dif-
ferentiation of AFSCs may follow a similar time course as MSCs in
terms of collagen type II expression. However, it has been shown
that the aggrecan is available in smaller amounts in cartilage
ECM than collagen type II [35], and we have also observed this in
our study (Fig. 4). The pattern of aggrecan expression observed in
this study is supported by data showing that during skeletogenesis,
chondroprogenitor determination and chondrocyte differentiation
are accompanied by dynamic ECM remodeling [36]. Aggrecan
expression in the ECM increases as chondrocytes differentiate
and become hypertrophic [36]. Interestingly, the higher levels of
aggrecan expression were observed in AFSC–agarose scaffolds cul-
tured in basal medium in comparison to chondrogenic mediumSCs seeded onto SPCL scaffolds) of the bilayered scaffolds after 14 days in the OC
() refers to the same culture medium without IGF-1. ‘‘Basal’’ represents the basic
l. Scale bar represents 100 lm.
d at osteochondral strategies: The inﬂuence of medium supplements in the
lls. Acta Biomater (2012), http://dx.doi.org/10.1016/j.actbio.2012.04.013
Fig. 11. AFSC viability (Calcein AM) of the chondrogenic layer (AFSCs in agarose hydrogel) of the bilayered scaffold, after 7 or 14 days in the OC culture media. IGF-1(+)
indicates culture medium supplemented with IGF-1 while IGF-1 () refers to the same culture mediumwithout IGF-1. ‘‘Basal’’ represents the basic medium currently used for
AFSC expansion and maintenance, and was used as a control. Scale bar represents 200 lm.
Fig. 12. Collagen type II expression (200 magniﬁcation) in the chondrogenic layer (AFSCs in agarose hydrogel) of the bilayered scaffold after 7 or 14 days in OC culture
medium. IGF-1(+) indicates culture medium supplemented with IGF-1 while IGF-1 () refers to the same culture medium without IGF-1. Cultures maintained in basal
medium were used as controls. Scale bar represents 100 lm. Insets represent the negative control and are stained with DAPI for cell density assessment and identiﬁcation in
the sections.
M.T. Rodrigues et al. / Acta Biomaterialia xxx (2012) xxx–xxx 9culture. Chondroprogenitor cells and chondrocytes express high
levels of collagen type II and increasing levels of aggrecan in the
ECM. Nevertheless, as chondrocytes move into a hypertrophic
state, low expression levels of collagen type II and high aggrecan
levels are observed [36]. Thus, by week 3, AFSCs may still be in
an early stage of chondrocyte differentiation.
4.2. AFSC–SPCL scaffold
Alkaline phosphatases (ALPs) are a group of enzymes found in
several organs. In living organisms bone related ALP is present in
vesicles secreted by osteoblasts to induce bone mineralization,
while in vitro ALP has been associated with ECM development
and maturation [34]. Consequently, ALP activity has been consid-Please cite this article in press as: Rodrigues MT et al. Bilayered constructs aime
osteogenic and chondrogenic differentiation of amniotic ﬂuid-derived stem ceered an osteogenic marker and is often evaluated in studies inves-
tigating stem cell differentiation to bone.
Our results show that some expression of ALP is already de-
tected on day 0, indicating that these levels are likely to be basal
amounts of ALP, naturally expressed in undifferentiated AFSCs
seeded on SPCL scaffolds. The signiﬁcant increment from day 0 to
day 7 (p < 0.05) is likely to be associated to the presence of osteo-
genic factors in the culture medium as well as the induction of
AFSCs towards an osteogenic phenotype, which was kept stable
from week 1 to week 2 in osteogenic medium (p > 0.05). Neverthe-
less, ALP activity signiﬁcantly increases in AFSC–SPCL constructs
after 21 days in osteogenic culture medium (p < 0.05). This incre-
ment is associated to a stage of osteogenic differentiation in which
the development and maturation of an ECM has a critical role ond at osteochondral strategies: The inﬂuence of medium supplements in the
lls. Acta Biomater (2012), http://dx.doi.org/10.1016/j.actbio.2012.04.013
Fig. 13. Aggrecan immunoﬂuorescence expression (200magniﬁcation) in the chondrogenic layer (AFSCs in agarose hydrogel) of the bilayered scaffold, after 7 or 14 days in
OC culture medium. IGF-1(+) indicates culture medium supplemented with IGF-1 while IGF-1() refers to the same culture medium without IGF-1. Culture in basal medium
was used as a control. Scale bar represents 100 lm. Insets represent the negative control and are stained with DAPI for cell density assessment and identiﬁcation in the
sections.
Fig. 14. Safranin-O staining of the chondrogenic layer (AFSCs in agarose hydrogel) of the bilayered scaffold after 14 days in OC culture medium. IGF-1(+) indicates culture
medium supplemented with IGF-1 while IGF-1 () refers to the same culture medium without IGF-1. ‘‘Basal’’ represents the basic medium currently used for AFSC expansion
and maintenance, and was used as a control. Magniﬁcation, 200.
10 M.T. Rodrigues et al. / Acta Biomaterialia xxx (2012) xxx–xxxthese cells. The results obtained herein are conﬁrmed by the liter-
ature [34].
Alizarin red (AR) staining is a versatile procedure used to iden-
tify calcium-rich deposits and it can provide both qualitative and
semi-quantitative data. Alizarin red stained AFSC–SPCL constructs
cultured for 3 weeks in osteogenic supplemented medium, evi-
dencing the presence of calciﬁed ECM. Furthermore, the calciﬁed
matrix produced by AFSCs is detectable throughout the scaffold,
indicating that cells are well distributed and the scaffold provides
the necessary support to assist the synthesis of a mineralized ECM.
After AR solubilization, calcium contents were measured in or-
der to quantify the amount of calciﬁed ECM produced by the cells.
The calcium content present in AFSC–SPCL is constant for up to
2 weeks in osteogenic medium (p > 0.05), showing similar values
to our baseline control, day 0, in which AFSCs from constructs were
cultured in basal medium. From day 14 to day 21, the amount of
calcium content signiﬁcantly increases (p < 0.05), being almost
50% higher than levels from day 14, suggesting that calcium is
being added to the ECM, inducing the formation of a mineralized
matrix in AFSC–SPCL constructs.Please cite this article in press as: Rodrigues MT et al. Bilayered constructs aime
osteogenic and chondrogenic differentiation of amniotic ﬂuid-derived stem ceSince AFSCs were able to produce a calciﬁed extracellular ma-
trix after 21 days in osteogenic culture, these cells were considered
osteoblastic-like cells, as osteoblasts are the bone cells associated
with calciﬁed matrix development.
Alizarin red and calcium content results support ALP activity
data as calciﬁcation of an ECM is essential in achieving a complete
in vitro bone-like ECM maturation.
4.3. Agarose–SPCL bilayered system
SEM morphological analysis was considered in this study so as
to evaluate cell distribution throughout the osteogenic layer of the
bilayered scaffolds and visualize the presence of mineralization
aggregates, also called nodules. In Fig. 7, a dense layer of cells are
covering SPCL scaffolds without completely closing the pores.
Not only did cell distribution occur homogeneously but the pres-
ence of open pores allows the income of nutrients and oxygen into
the inner sections of the construct. Moreover, the aggregates indi-
cated by white arrows in Fig. 7 represent mineralization nodules
typically associated to a calciﬁed ECM. EDS analysis has beend at osteochondral strategies: The inﬂuence of medium supplements in the
lls. Acta Biomater (2012), http://dx.doi.org/10.1016/j.actbio.2012.04.013
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including bone tissue [38], and was used to conﬁrm and measure
the calcium and phosphate composition on these structures.
Statistically, the percentage of atomic concentrations of calcium
and phosphorus ions is preserved with the culturing time in both
broad and mineral aggregates analysis. However, and as expected,
the levels of these ions are signiﬁcantly increased in the analysis
over the mineral aggregates. When osteoblasts of native bone tis-
sue become entrapped in bone ECM, these cells signiﬁcantly re-
duce their metabolism as part of the natural process of bone
mineral formation. As a consequence, cell proliferation rate de-
creases as cells are entrapped in the mineralized matrices they pro-
duced, which ultimately stabilizes the synthesis of ECM. In a
similar way, the stability of calcium and phosphorus ions with time
may be related to the response of AFSCs to the culture media and
media stimuli to assist the production of mineralized matrix after
14 days in the bilayer co-cultures. During the process of bone hard-
ening during aging, the Ca/P ratio gradually increases from 1 to
1.67, the hydroxyapatite ratio reported for healthy bone [39]. Thus,
in this study Ca/P ratios were determined in the osteogenic layer of
the bilayer system for each culturing condition and time point. The
best results in terms of Ca/P ratio were observed in basal medium
conditions, which increase with time in culture, and whose Ca/P
ratio is the closest observed to that seen in natural bone. Although
IGF-1 has been shown to be important for bone and cartilage tissue
development, we did not ﬁnd that the presence of this growth fac-
tor had any signiﬁcant effect on the maintenance of the osteogenic
phenotype of cells cultured in OC mediumwith IGF-1. According to
the EDS data, AFSCs seem not to require supplementation provided
by the osteochondral medium without IGF-1 to maintain the oste-
ogenic phenotype in the developed bilayered system.
RunX-2 is an important transcription factor involved in osteo-
genic development and exogenous expression, which has been
shown to enhance osteoblast-speciﬁc gene expression in rat bone
marrow stromal cells as well as biological mineral deposition
[40]. In the basal medium, RunX-2 expression was almost nonexis-
tent, which indicates that in OC media with or without IGF, the
osteogenic process is dynamic and evolving, and that mineraliza-
tion development may still be taking place, since high levels of
RunX2 expression have been shown to maintain the mineralization
capacity of expanded marrow cells [40].
Conversely, safranin-O staining suggests that the combination
of other factors besides IGF-1 in the osteochondral medium main-
tains a higher level of chondrogenesis in the constructs, thus
increasing the safranin-O staining in the constructs cultured in
the OC medium.
Collagen type II and aggrecan expression were present in the
chondrogenic layer of the bilayered constructs cultured in OC med-
ium, indicating that in this media, AFSCs continue to produce ECM.
Although aggrecan levels increase after 2 weeks in osteochondral
media (with or without IGF-1), the collagen II levels remain stable,
thus it is unlikely that AFSC-derived chondrocyte-like cells became
hypertrophic in these constructs. Since the amount of collagen II is
lower in basal medium, and the aggrecan expression barely pres-
ent, the supplements in the osteochondral media seem to be
important for long-term maintenance of a chondrogenic ECM.5. Conclusions
This study demonstrated that AFSCs seeded onto SPCL scaffolds
or encapsulated in agarose hydrogels remained viable even after
these constructs were moved into the novel OC culture media. Fur-
thermore, in the osteogenic layer (SPCL), osteogenically differenti-
ated AFSCs did not require the OC media to maintain an osteogenic
phenotype for up to 14 days, as they were able to continue produc-Please cite this article in press as: Rodrigues MT et al. Bilayered constructs aime
osteogenic and chondrogenic differentiation of amniotic ﬂuid-derived stem ceing mineralized ECM even when cultured in basal culture medium.
In agarose hydrogels, encapsulated AFSCs produced an ECM-rich in
collagen type II and a mild presence of aggrecan protein. When cul-
tured in OC media, the expression of collagen II is stable and aggre-
can expression increases, although keeping low levels. Safranin-O
staining clearly indicated that the cells continued to produce a car-
tilage-like ECM in OC medium without IGF supplement. In this
bilayered system, IGF was not essential for the maintenance of
chondrogenic or osteogenic phenotypes in differentiated AFSCs as
evidenced by marker expression studies. However, the other sup-
plements in the OC medium were revealed to be relevant for
achieving long-term differentiation results.
This OC co-culture medium could be advantageous not only to
simplify cell culture procedures but also to allow physical interac-
tion between osteogenic and chondrogenic phenotypes while
ensuring that the induced phenotype of chondrocytes and osteo-
blasts is maintained. In addition, this medium would reduce the
time and production costs of a tissue engineered product and move
it closer to a clinically applicable strategy for joint repair. Finally,
the development of a bilayered OC system for tissue engineering
of bone/cartilage interfaces could better mimic the integration of
bone and cartilage in an OC defect by providing scaffolds that ad-
dress tissue speciﬁc needs. In this study, a bilayered scaffold of this
type was successfully created in which both osteogenically and
chondrogenically differentiated AFSCs maintained long term via-
bility and phenotypic expression in vitro. Thus, the integrated aga-
rose–SPCL scaffold proved to be functional it and may lead to the
development of new strategies for OC repair and regeneration.Conﬂict of interest statement
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